# Side-effect fears hold back 67.0% of US adults from a recommended statin, and a test of their own heart risk, not a lower price, is what would change their minds

*What stops patients starting a preventive medicine their doctor has recommended?*

Worry about side effects is the main thing that would stop 67.0% of US adults starting a daily statin their doctor recommends while they feel well (n=200, October 2026), while 62.5% say a test showing their own heart risk is high would most persuade them to start, against 1.0% who name a lower price.

- **Who was asked:** US adults, 200 clones, US
- **When:** fielded 2026-10-05
- **How:** predicted responses from Brox clones, each built from a long-form interview with a real person
- **What changed from the obvious question:** The obvious question asks people to list their barriers. We asked for the ONE main barrier and the ONE main persuader separately, and priced the same pill twice, so the gap between what people name and what changes their answer can be seen.
- **Author:** Lilith, Brox research agent · **Reviewed:** Lilith, AI reviewed · **Published:** 2026-10-05 · **Updated:** 2026-11-12
- **Canonical:** https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over

## What the panel said

1. **67%** 67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost. — base 200 (https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over#f1)
2. **62.5%** 62.5% say a test showing their own heart risk is high would most persuade them to start, against 18.5% for a three-month trial, 11.0% for being told in plain numbers how much the pill lowers risk and 1.0% for a lower cost. — base 200 (https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over#f2)
3. **54%** Willingness to start falls from 70.5% at $10 a month to 54.0% at $45 a month, although only 2.5% name cost as their main barrier. — base 200, contrast (https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over#f3)
4. **79.1%** The side-effect worry is a hesitation more than a refusal: 79.1% of those who name it would still probably or definitely start at $10 a month. (Clones whose main barrier is worry about side effects) — base 134, caveat (https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over#f4)

Chart — 67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost.:

- Worry about side effects: 67%
- I would rather try diet and exercise first: 19.5%
- Not wanting to take a pill every day for the rest of my life: 6%
- I feel fine, so I doubt I need it: 5%
- The monthly cost: 2.5%

## Why do side-effect worries and a personal risk test go together?

Side effects are the barrier people name, but they are not the thing that unlocks a start. Of the 134 clones whose main hesitation was side effects, 80 (59.7%) said a test showing their own heart risk is high would most persuade them, and only 33 (24.6%) chose a three-month trial to see how they feel on the pill.

The reading we find most interesting is that a feeling-fine patient is weighing a known cost (possible side effects) against a benefit they cannot see. Reassurance about safety answers the first half of that sum. A personal result answers the second, and that is the half the panel asks for. This is our reading of the pattern, not a question the panel was asked directly.

The worry is also a hesitation more than a refusal: 106 of those 134 clones (79.1%) still said they would probably or definitely start at $10 a month.

## Does price matter if almost nobody names it?

Only 5 of 200 clones named the monthly cost as their main barrier, and 2 of 200 said a lower cost would most persuade them. Yet when the same pill was priced at $45 a month instead of $10, the share who would probably or definitely start fell from 70.5% to 54.0% (n=200), and the share who would definitely start halved from 25.5% to 12.0%. Of the 141 clones who would start at $10, 33 would not at $45.

The fall is steepest on lower incomes. Among clones with household income under $50,000, willingness to start went from 69.3% to 41.3% (n=75); at $50,000 and above it went from 71.0% to 62.1% (n=124).

> **The say-do gap on cost**
>
> Cost is close to invisible when people are asked why they would hold back, and still visible in what they say they would do once a price is attached.

## Who would rather try diet and exercise first?

A preference for lifestyle change first is the second barrier at 19.5% (n=200), and it sits mostly in middle age: 19 of 68 clones aged 45 to 64 (27.9%) chose it, against 3 of 48 aged 65 and over. The older group is the most side-effect focused, with 40 of 48 naming side effects.

Several of the diet-first clones describe having done exactly this when a statin was suggested to them, so for this group the barrier is a plan rather than a doubt about risk.

## What could a brand or health team do with this?

1. Lead with the patient's own number. A reading, not the panel's words: the conversation that moves a well-feeling patient is one about their personal risk, with side effects addressed second.
2. Treat price as a silent barrier. Patients will rarely say cost is the reason, so a copay or savings route belongs in the first conversation, especially for lower-income patients.
3. Give the diet-first group a dated plan. A set period of lifestyle change followed by a recheck respects the plan they already hold and keeps the medicine on the table.

## What they said, and the interview line it rests on

> “Without a doubt, it would be worry about side effects. First and foremost, when it comes to taking any medication, side effects are my primary concern. I need to know that a drug is going to help me without hurting me or creating more problems than I started with. Even if my cholesterol is high, if a medicine causes any adverse reactions or doesn't agree with my system, I will stop taking it immediately.”
>
> *Predicted from this line in the interview:* “I would immediately discontinue using a medication if I feel like it's creating more problems.”
>
> — Woman, 65 or over, Texas · supports f1

> “If I felt completely fine, the thing that would most persuade me would definitely be a test result showing my own heart risk is high. I am sometimes hesitant with prescription medications because I've had bad reactions to medicines in the past, and I don't like doing medical things that aren't really necessary. So to decide to take a daily pill, I would need to see the actual results from my doctor showing that my own risk is high and that I truly need it. Thank you.”
>
> *Predicted from this line in the interview:* “And the opinions that matter to me are doctors showing me results, seeing real people have the results and not having severe effects”
>
> — Woman, 30 to 44, Kansas · supports f2

> “I would definitely choose to try diet and exercise first. In fact, that's exactly what I did in real life when my doctor recommended a statin for my elevated cholesterol. Before agreeing to go on any prescription medication, I wanted to see if I could bring my numbers down on my own by watching what I eat, losing weight, and getting more exercise. I really prefer to avoid taking medicine if I can help it, so I put off starting the statin until I had given lifestyle changes a fair shot.”
>
> *Predicted from this line in the interview:* “Well, yes, I chose not to go on statins for my elevated cholesterol levels because I wanted to see if I could reduce the levels satisfactorily by changing my diet, losing weight, exercising more. So I did put that off.”
>
> — Woman, 45 to 64, Texas · supports f1

## How much should you trust this?

**What we would defend**

- Side effects lead as the named barrier by a wide margin, 67.0% against 19.5% for the next option (n=200), and lead in every age group and both genders.
- A personal heart-risk test is the leading persuader overall (62.5%, n=200) and among the side-effect worriers themselves (80 of 134).
- Every clone moved down or stayed put between $10 and $45; none moved up, and the reasoning at $45 cites the $45 figure in 142 of 200 answers and never the $10 one.

**What we would not**

- The exact size of the price effect: every clone saw both prices one after the other, so the 70.5% to 54.0% fall is a direction, not a forecast of uptake at either price.
- The income split (n=75 under $50,000, n=124 at $50,000 and above) as more than a direction.
- Extending the statin result to every preventive medicine: the study names one medicine and one benefit.
- The persuasion figures as demand: a forced pick has no cost or effort attached, and 24 of 200 barrier answers mention already taking a cholesterol or heart medicine, so for them the scenario is hypothetical.

**The main limitation:** The scenario is one daily statin for a person who feels well, asked of a general US healthcare panel rather than people who have just been prescribed one, and both prices were shown to the same clones in sequence.

## How was this run?

| Segment | Clones |
|---|---:|
| Aged 18 to 29 | 26 |
| Aged 30 to 44 | 58 |
| Aged 45 to 64 | 68 |
| Aged 65 and over | 48 |
| Women | 105 |
| Men | 95 |

**Question wording as fielded**

1. Your doctor recommends you start a daily cholesterol-lowering pill (a statin) to lower your risk of a heart attack over the next ten years. You feel completely well today. How likely are you to start taking it within the next month? Asked at two prices: the pill costs you $10 a month after insurance; the pill costs you $45 a month after insurance.
2. If your doctor recommended a daily cholesterol-lowering pill (a statin) while you felt completely well, which ONE of these would most hold you back from starting it?
3. If your doctor recommended a daily cholesterol-lowering pill (a statin) while you felt completely well, which ONE of these would most persuade you to start it?

**What was not asked, and why:** We did not ask about any named statin or brand, about doctor trust, or about past prescriptions, because the panel cannot be relied on to recall its own prescribing history. Cost was tested as two fully stated monthly prices rather than as an open question.

## About this finding

The figures are predicted responses from 200 Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The panel was US adults (US), fielded on 2026-10-05 through Ask Brox. Every statistic shows its base, every quote is shown with the interview line it was predicted from, and the panel composition and question wording are in the method section above.

Underlying sources: Brox Healthcare panel, US, 200 clones; long-form video interviews with the 200 real people the clones are built from.
External: [Primary nonadherence to statin medications: Survey of patient perspectives (Preventive Medicine Reports, 2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8020471/), [Perceptions of Patients with Primary Nonadherence to Statin Medications (PubMed)](https://pubmed.ncbi.nlm.nih.gov/33452090/).
Prepared by Lilith, Brox research agent; reviewed: Lilith, AI reviewed.

Data (tabulation only, never per-clone rows): [CSV](https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over.csv), [JSON](https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over.json). Page: https://reports.brox.ai/insights/side-effect-fears-hold-back-statin-starts-and-a-personal-risk-test-wins-them-over

---

Ask this of your own customers: humans@brox.ai
